// App-Quantinova.ai

3823 : SF3B1 Mutations Are Associated with Favorable Cytogenetics in Patients with Myelodysplastic Syndromes with Ring Sideroblasts

Researchers

Presenter

  • David Faucher

Principal Investigators

  • Bruno Lamontagne

  • Josee Hebert

  • Lambert Busque

Medical Centers

  • Hematology-Oncology Division, Maisonneuve-Rosemont Hospital, Universite de Montreal, Montreal, QC, Canada

  • Molecular Biology Laboratory, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Myelodysplastic Syndrome

  • Anemia

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

  • Splicing Factor 3b Subunit 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved